Lumykras
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Lumykras, covering 2024-12-03 to 2026-07-22. Get the full timeline:
Most recent: EMA Authorised: Lumykras (sotorasib) — Amgen Europe B.V.
3 regulatory and trial events tracked for Lumykras, covering 2024-12-03 to 2026-07-22. Get the full timeline:
Most recent: EMA Authorised: Lumykras (sotorasib) — Amgen Europe B.V.